The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia

British Journal of Ophthalmology

Volumn 96, Issue 9, 2012, Pages 1246-1251

  Liang, Kun ^a   Jiang, Zhengxuan ^a   Zhao, Bingying ^a   Shen, Jijia ^a   Huang, Dake ^a   Tao, Liming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MEDIUM CHAIN TRIACYLGLYCEROL; TOLONIUM CHLORIDE; VASCULOTROPIN;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DUAL IMMUNOFLUORESCENCE TEST; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAST CELL; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PTERYGIUM;

ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; CONJUNCTIVA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MAST CELLS; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PTERYGIUM; TOLONIUM CHLORIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866083142     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301540     Document Type: Article

References (25)

1. Kase S, Takahashi S, Sato I, et al. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 2007;91:958-61.
2. Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives [Review]. Int J Mol Med 2009;23:439-47.
3. Liang K, Jiang Z, Ding BQ, et al. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva. Mol Vis 2011;17:1687-93.
4. Marcovich AL, Bahar I, Srinivasan S, et al. Surgical management of pterygium. Int Ophthalmol Clin 2010;50:47-61.
5. Ando R, Kase S, Ohashi T, et al. Tissue factor expression in human pterygium. Mol Vis 2011;17:63-9.
6. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
8. Aspiotis M, Tsanou E, Gorezis S, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye (Lond) 2007;21:1095-101.
9. Powers MR, Qu Z, O'Brien B, et al. Immunolocalization of bFGF in pterygia: association with mast cells. Cornea 1997;16:545-9.
10. Nakagami T, Murakami A, Okisaka S, et al. Pterygium and mast cells - mast cell number, phenotype, and localization of stem cell factor (In Japanese). Nippon Ganka Gakkai Zasshi 1997;101:662-8.
11. Ribatti D, Crivellato E, Roccaro AM, et al. Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 2004;34:1660-4.
12. Ribatti D, Nico B, Maxia C, et al. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007;11:585-9.
13. Szukiewicz D, Gujski M, Maslinska D, et al. Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture - influence of hypoxia. Inflamm Res 2005;54(Suppl. 1):S82-3.
14. Khurana AK. Ophthalmology. New Delhi, India: New Age International Publishers, 2005:105-6.
15. Zhao Y, Ju F, Wang L, et al. The expression of alphaA- and betaB1-crystallin during normal development and regeneration, and proteomic analysis for the regenerating lens in Xenopus laevis. Mol Vis 2011;17:768-78.
16. Wong YW, Chew J, Yang H, et al. Expression of insulin-like growth factor binding protein-3 in pterygium tissue. Br J Ophthalmol 2006;90:769-72.
17. Khalfaoui T, Mkannez G, Colin D, et al. Immunohistochemical Analysis of Vascular Endothelial Growth Factor (VEGF) and P53 Expression in Pterygium from Tunisian Patients. Paris: Pathol Biol, 2009.
18. Lee DH, Cho HJ, Kim JT, et al. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001;20:738-42.
19. Butrus SI, Ashraf MF, Laby DM, et al. Increased numbers of mast cells in pterygia. Am J Ophthalmol 1995;119:236-7.
20. Livezeanu C, Craitoiu MM, Manescu R, et al. Angiogenesis in the pathogenesis of pterygium. Rom J Morphol Embryol 2011;52:837-44.
21. Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004;23:195-228.
22. Bahar I, Kaiserman I, McAllum P, et al. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr Eye Res 2008;33:23-8.
23. Hosseini H, Nejabat M, Khalili MR. Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses 2007;69:925-7.
24. Szukiewicz D, Szukiewicz A, Maslinska D, et al. Mast cell-derived vascular endothelial growth factor (VEGF) and microvascular density in diabetic placentae. Inflamm Res 2003;52(Suppl. 1):S09-10.
25. Tan ST, Wallis RA, He Y, et al. Mast cells and hemangioma. Plast Reconstr Surg 2004;113:999-1011.